The impact of body mass index (BMI) on antiplatelet monotherapy strategy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Heart, Artery and Coronary DiseasesTherapy and Intervention
Do you want to read an article? Please log in or register.